{"schema_version":"secwatch.filing_event.v1","accession":"0001562762-22-000404","form_type":"8-K","ticker":"CHE","cik":"0000019584","company_name":"CHEMED CORP","filed_at":"2022-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.058307+00:00","generated_at":"2026-06-22T21:58:01.030970+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Chemed Q3 revenue down 2.3% to $526M; raises 2022 adjusted EPS guidance to $19.60-$19.70","bullets":["GAAP diluted EPS of $3.78; adjusted diluted EPS of $4.74, down 6.3% YoY.","VITAS net revenue fell 6.6% to $297M; ADC down 4.4% to 17,242; admissions down 16.6%.","Roto-Rooter revenue rose 3.9% to $230M; adjusted EBITDA margin improved 50bps to 30.2%.","Company repurchased 50,000 shares for $23.9M at avg cost $477.68; $101M authorization remaining.","2022 adjusted EPS guidance raised to $19.60-$19.70 from $19.30-$19.50; VITAS revenue forecast down 4.5%-5%."],"urls":{"canonical":"https://secwatch.observer/filing/0001562762-22-000404","json":"https://secwatch.observer/filing/0001562762-22-000404.json","markdown":"https://secwatch.observer/filing/0001562762-22-000404.md","text":"https://secwatch.observer/filing/0001562762-22-000404.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/0001562762-22-000404-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/che-20221031x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T21:58:01.030970+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc9779b05926eeb7c49f413bcd19ec968650660a","claim":"CHEMED CORP reported third quarter ended September 30, 2022 results: revenue $526 million, EPS $3.78. Guidance raised.","evidence_excerpt":"Consolidated operating results: · Revenue declined 2.3% to $526 million · GAAP Diluted Earnings-per-Share (EPS) of $3.78 · Adjusted Diluted EPS of $4.74, a decline of 6.3%","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/19584/000156276222000404/0001562762-22-000404-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Revenue","value":"$526 million"},{"label":"EPS","value":"$3.78"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}